MoonLake Immunotherapeutics Cash Flow Statement (2021-2026) | MLTX

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-6.29M-53.64M-15.88M-17.42M-14.74M-16.47M-12.22M-12.35M-11.62M-7.89M-13.97M-24.76M-36.11M-46.40M-40.56M-56.05M-70.69M-63.02M-69.71M-61.80M
Depreciation and Depletion (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.02M0.03M0.03M
Share-based Compensation (Quarter)
1.86M9.05M1.99M2.48M2.59M2.60M2.58M1.50M1.43M1.61M1.68M-1.31M4.98M-4.79M13.36M2.55M
Cash from Operations (Quarter)
-2.02M-35.18M-14.19M-20.76M-9.35M-11.60M-9.02M-12.16M-9.25M-12.34M-14.95M-27.89M-25.28M-48.47M-38.14M-54.53M-44.54M-58.79M-66.29M-55.56M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.33M0.37M0.32M0.38M0.38M0.72M0.80M0.72M0.80M0.90M
Change in Working Capital
Change in Account Payables (Quarter)
0.21M1.57M2.25M-3.03M0.27M-0.80M3.57M0.53M-0.96M-1.57M1.65M1.66M5.57M-1.72M3.01M5.07M8.20M4.27M-6.17M-6.34M
Change in Accured Expenses (Quarter)
2.10M4.51M-1.35M-0.11M1.90M2.24M-3.95M-0.67M1.42M2.87M-2.81M1.69M2.11M4.17M-1.56M-1.81M12.86M-6.90M7.12M3.79M
Investing Activities
Capital Expenditures (Quarter)
0.03M0.05M0.02M-2.001.000.34M0.18M0.04M-0.00M-1.11M0.75M-0.00M
Change in Acquisitions & Divestments (Quarter)
9.90M19.65M12.68M1.36M117.15M59.12M-1.30M87.59M-0.21M144.83M205.91M88.40M29.26M59.17M59.07M
Cash from Investing Activities (Quarter)
-0.01M-0.05M-0.02M2.00-42.23M9.90M19.65M12.68M-174.38M116.87M-28.80M-87.74M58.28M-147.33M56.25M88.25M88.40M-29.91M0.10M0.32M
Financing Activities
Other financing activities (Quarter)
0.00M0.00M-0.00M482.45M0.09M52.54M0.10M0.38M71.92M0.17M0.55M
Cash from Financing Activities (Quarter)
0.50M43.26M15.00M104.69M0.00M451.29M28.42M50.98M0.18M0.15M73.12M0.48M72.39M30.64M234.62M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
14.60M52.54M6.01M44.31M
Additional items
Exchange Rate Effect (Quarter)
-0.00M0.00M-0.01M-0.05M0.07M-0.01M-535.00-0.14M0.01M0.06M0.05M-0.02M-0.33M0.42M-0.09M1.39M-0.28M0.09M-0.48M0.03M
Change in Cash (Quarter)
-1.53M8.04M0.80M83.87M-51.50M-1.70M10.62M451.66M-183.62M133.00M7.27M-115.65M32.86M-195.23M91.14M35.12M44.05M-16.22M-36.03M179.41M
Free Cash Flow (Quarter)
-2.05M-35.23M-14.20M-20.76M-9.35M-11.60M-9.02M-12.16M-9.25M-12.34M-14.95M-27.89M-25.62M-48.65M-38.17M-54.53M-44.54M-58.79M-66.29M-55.56M
Net Cash Flow (Quarter)
-1.53M8.04M0.80M83.92M-51.58M-1.69M10.62M451.80M-183.63M132.94M7.23M-115.63M33.19M-195.65M91.23M33.72M44.34M-16.31M-35.54M179.39M